-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

613A.O1.6 613. Acute Myeloid Leukemias: Clinical and Epidemiological: Innovations in Prognostication

Symposia: Acute Myeloid Leukemias: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, epidemiology, health outcomes research, Clinical Research, Therapies
Monday, December 11, 2023: 10:30 AM-12:00 PM
Room 6B (San Diego Convention Center)
Moderators:
Ashish Bajel, FRACP, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital and Douglas Tremblay, MD, Icahn School of Medicine at Mount Sinai
Disclosures:
Bajel: Abbvie: Honoraria; Amgen: Honoraria, Speakers Bureau; Pfizer: Honoraria; Astellas: Honoraria; Novartis: Honoraria; Gilead-Kite: Honoraria; Takeda: Honoraria; Jazz: Honoraria; Shoreline: Honoraria; Senti-Bio: Honoraria. Tremblay: CTI Biopharma: Consultancy, Research Funding; Novartis: Consultancy; AbbVie: Consultancy; Sierra Oncology: Consultancy; GSK: Consultancy; Cogent Biosciences: Consultancy; Astellas Pharma: Research Funding; Gilead: Research Funding.
10:30 AM

Marius Bill, MD, PhD1*, Jan-Niklas Eckardt1*, Christian Rausch2*, Klaus H Metzeler, MD3, Karsten Spiekermann, MD4*, Sebastian Stasik, PhD5*, Tim Sauer, MD6*, Sebastian Scholl, MD7*, Andreas Hochhaus, MD8, Martina Crysandt, MD9*, Tim H. Brümmendorf10, Utz Krug, MD11*, Bernhard Wörmann, MD12*, Wolfgang Hiddemann, MD4*, Dennis Görlich, PhD13, Maria Cristina Sauerland, MD13*, Björn Steffen, MD14*, Hermann Einsele, MD, PhD15*, Andreas Neubauer, MD16, Andreas Burchert, MD17, Kerstin Schaefer-Eckart, MD18, Wolfgang E. Berdel, MD19, Christoph Schliemann, MD20*, Stefan W. Krause, MD21*, Mathias Hanel, MD22, Maher Hanoun, MD, PhD23*, Martin Kaufmann, MD24, Lars Fransecky25*, Jan Braess, MD26*, Leo Ruhnke, MD27*, Johannes Schetelig, MD, MSc28,29, Jan Moritz Middeke, MD1*, Hubert Serve, MD30, Claudia D Baldus, MD31*, Uwe Platzbecker, MD32, Carsten Müller-Tidow, MD6*, Martin Bornhäuser, MD5*, Tobias Herold, MD4*, Christian Thiede, MD5 and Christoph Röllig, MD, MSc27*

1Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
2Laboratory for Leukemia Diagnostics, Department of Medicine III,, LMU University Hospital, LMU Munich, Munich, Germany
3Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Leipzig Medical Center, Leipzig, NA, Germany
4Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
5Department of Internal Medicine 1, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany
6Heidelberg University Hospital, Heidelberg, Germany
7Klinik für Innere Medizin II, Jena University Hospital, Jena, Germany
8Department Hematology and Oncology, Klinik für Innere Medizin II, Jena, Germany
9Department of Hematology and Oncology, University Hospital RWTH Aachen and Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIOABCD), Aachen, Germany
10Center for Integrated Oncology - Aachen Bonn Cologne Duesseldorf (CIO-ABCD), Aachen, Germany
11Department of Medicine III, Hospital Leverkusen, Leverkusen, DEU
12Department of Hematology, Oncology and Tumor Immunology, Charité, Berlin, Germany
13Institute of Biostatistics and Clinical Research, University of Münster, Muenster, Germany
14Department of Hematology and Oncology, Unversity Hospital Frankfurt, Frankfurt, Frankfurt am Main, Germany
15Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
16Department of Hematology, Oncology and Immunology, Phillips-University Marburg, Marburg, Germany, Marburg, Germany
17Hämatologie, Onkologie und Immunologie, Universitätsklinikum Gießen und Marburg, Standort Marburg, Marburg,, Germany
18Med. Clinic 5, BMT Unit, Nurnberg, DEU
19Department of Medicine A, Hematology and Oncology, University Hospital Muenster, Muenster, Germany
20Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
21Universitätsklinikum Erlangen, Erlangen, Germany
22Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany
23Department of Hematology, University Hospital Essen, Essen, Germany
24Department of Hematology, Oncology and Palliative Care, Robert Bosch Hospital, Stuttgart, Germany
25Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany
26Hospital Barmherzige Brueder Regensburg, Regensburg, Germany
27Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany
28TU Dresden, Dresden, Saxony, Germany
29DKMS Group gGmbH, Dresden, Germany
30Department of Internal Medicine II, Hematology and Oncology, Goethe University Hospital Frankfurt, Frankfurt, Germany
31University Hospital Schleswig-Holstein, Department of Hematology and Oncology, Campus Kiel, Kiel, Germany
32University Leipzig Medical Center, Leipzig, Germany

10:45 AM

Yazan Abu-Shihab, MD1*, Deedra Nicolet2,3, Krzysztof Mrózek, MD, PhD4, Andrew Stiff, MD, PhD5, Christopher J. Walker, PhD2,6*, Jill Buss, BS4,6, Alice Mims, MD7, Christopher C. Oakes, PhD8, Karilyn T. Larkin, MD9, James S. Blachly10, Andrew J Carroll, PhD11, William Blum, MD12, Bayard L Powell, MD13, Jonathan E Kolitz, MD14, Richard M Stone, MD15, Geoffrey L Uy, MD16, Wendy Stock, MD17, Jennifer A. Woyach, MD6, John C. Byrd, MD18, Dimitrios Papaioannou, MD*19,20, Ann-Kathrin Eisfeld, MD*2,20 and Kellie Archer, PhD*20,21*

1The Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH
2Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University, Columbus, OH
3Alliance Statistics and Data Center, The Ohio State University Comprehensive Cancer Center, Columbus, OH
4Clara D. Bloomfield Center for Leukemia Outcomes Research, The Ohio State University Comprehensive Cancer Center, Columbus, OH
5Depatment of Internal Medicine, Division of Hematology, Ohio State University, Columbus, OH
6The Ohio State University Comprehensive Cancer Center, Columbus, OH
7Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
8OSU, Columbus, OH
9Department of Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
10Department of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
11Department of Genetics, University of Alabama at Birmingham, Birmingham, AL
12Winship Cancer Institute of Emory University, Atlanta, GA
13Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC
14Northwell Health, Lake Success, NY
15Dana-Farber Cancer Institute, Boston, MA
16Division of Oncology, Washington University School of Medicine, Saint Louis, MO
17University of Chicago Medicine, Chicago, IL
18Department of Internal Medicine, University of Cincinnati, Cincinnati, OH
19Department of Medicine, Division of Hematology/Oncology, NYU Grossman School of Medicine, New York, NY, New York, NY
20Equal contribution, Equal Contribution
21The Ohio State University Comprehensive Cancer Center, Columbus, OH, Columbus, OH

11:00 AM

Alex Bataller, MD, PhD1*, Hagop M. Kantarjian, MD1, Tapan M. Kadia, MD1, Naval Daver, MD1, Courtney D. DiNardo, MD, MSc1, Gautam Borthakur, MD1, Nicholas J. Short, MD1, Musa Yilmaz, MD1*, Ghayas C. Issa2, Yesid Alvarado Valero, MD1, Guillermo Montalban-Bravo, MD1, Abhishek Maiti, MD3, Hussein A Abbas, MD, PhD1, Elias Jabbour4, William G. Wierda, MD, PhD2, Guillermo Garcia-Manero, MD2 and Farhad Ravandi, MD, MBBS1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, MD Anderson Cancer Center, Houston, TX
4University of Texas M.D. Anderson Cancer Ctr., Houston, TX

11:15 AM

Niek G. Van Der Maas, MSc1*, Dimitri Breems, MD, PhD2, Clara Klerk, MD, PhD3*, Thomas Pabst, MD4,5, Patrycja Gradowska, PhD1,6*, Bart J. Biemond7, Jurgen Kuball, MD8, Janine Van Elssen, MD, PhD9*, Otto Visser, MD PhD10*, Marie-Christiane Vekemans, MD11*, Carlos Graux12*, Johan Maertens, MD, PhD13*, H. Berna Beverloo, PhD1*, Peter J. M. Valk, PhD1, Gert J. Ossenkoppele, MD, PhD14*, Bob Lowenberg, MD, PhD1, Gerwin A. Huls, Prof.15, Jan J. Cornelissen, MD, PhD1* and Jurjen Versluis, MD, PhD1*

1Erasmus Medical Center Cancer Institute, Rotterdam, Netherlands
2Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium
3Dijklander Hospital, Amsterdam, Netherlands
4Institute of Medical Oncology, Berne, Switzerland
5Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland
6HOVON Foundation, Rotterdam, Netherlands
7Department of Hematology, Amsterdam University Medical Centers, location University of Amsterdam, Amsterdam, Netherlands
8Utrecht University, University Medical Centre, Utrecht, Netherlands
9Maastricht University Medical Center, Maastricht, Netherlands
10Department of Hematology, Isala Hospital, Zwolle, Netherlands
11Cliniques Universitaires Saint-Luc, Brussels, Belgium
12University Hospital Center Namur (Godinne), Université Catholique de Louvain, Yvoir, Belgium
13Department of Hematology, University Hospitals Leuven, Leuven, Belgium
14Cancer Center Amsterdam, Amsterdam UMC, location VUMC, Amsterdam, Netherlands
15University Medical Center, University Groningen, Groningen, Netherlands

11:30 AM

Constance Regina Baer, PhD, Sandra Huber, PhD*, Gregor Hoermann, MD, PhD, Manja Meggendorfer, PhD, Stephan Hutter, PhD*, Wolfgang Kern, MD, Torsten Haferlach, MD, PhD and Claudia Haferlach, MD

MLL Munich Leukemia Laboratory, Munich, Germany

11:45 AM

Richard Aplenc, MD, PhD1, Yimei Li, PhD2*, Julianne Ani, MPH3*, Caitlin W. Elgarten, MD1, Lisa D'Errico3*, Todd Cooper, DO4, E. Anders Kolb, MD5, Maria Monica Gramatges, MD, PhD6, Meret Henry, MD7, Tamara P. Miller, MD8, Rajen Mody, MD, MS9*, Elaine Morgan, MD10, Regina M. Myers, MD3, Jessica A. Pollard, MD11, Alix Seif, MD, MPH3, Brian T. Fisher, DO, MPH, MSCE12* and Kelly D. Getz, PhD13*

1Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
2Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
3Children's Hospital of Philadelphia, Philadelphia, PA
4Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Seattle Children's Hospital, Seattle, WA
5Leukemia & Lymphoma Society, Bronx, NY
6Texas Children's Hospital, Houston, TX
7Children's Hospital of Michigan, Detroit, MI
8Department of Pediatrics, Emory University School of Medicine, Decatur, GA
9University of Michigan, Ann Arbor, MI
10Children's Memorial Hosp., Chicago, IL
11Dana Farber Cancer Institute/Boston Children's Hospital, Boston, MA
12Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA
13Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

*signifies non-member of ASH